Last quarter (Q2 2022), Shandong Weigao Group Medical Polymer Co's total revenue was $6.98B, an increase of 33.74% from the same quarter last year. In Q2, Shandong Weigao Group Medical Polymer Co's net income was $―. See Shandong Weigao Group Medical Polymer Co’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 38.04B	$ 13.15B	$ 11.62B	$ 10.38B	$ 8.81B	$ 6.29B
Cost of Revenue	$ ―	$ 5.88B	$ 5.12B	$ 3.87B	$ 3.42B	$ 2.30B
Gross Profit	$ ―	$ 7.27B	$ 6.50B	$ 6.51B	$ 5.39B	$ 3.99B
Operating Expense	$ ―	$ 4.15B	$ 3.94B	$ 4.08B	$ 3.67B	$ 2.64B
Operating Income	$ ―	$ 3.12B	$ 2.56B	$ 2.44B	$ 1.72B	$ 1.36B
Net Non Operating Interest Income Expense	$ ―	$ 3.55M	$ -63.96M	$ -268.60M	$ -113.60M	$ 48.35M
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ 2.84B	$ 2.57B	$ 2.25B	$ 1.78B	$ 1.53B
Tax Provision	$ ―	$ 415.09M	$ 358.42M	$ 327.14M	$ 258.43M	$ 224.40M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ 2.24B	$ 2.09B	$ 1.85B	$ 1.47B	$ 1.73B
Basic EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Basic Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ 10.03B	$ 9.06B	$ 7.95B	$ 7.09B	$ 4.94B
Net Income From Continuing And Discontinued Operation	$ ―	$ 2.24B	$ 2.09B	$ 1.85B	$ 1.47B	$ 1.73B
Normalized Income	$ ―	$ 2.53B	$ 2.03B	$ 1.91B	$ 1.48B	$ 1.20B
Interest Expense	$ ―	$ 140.40M	$ 178.94M	$ 397.95M	$ 284.41M	$ 23.89M
EBIT	$ ―	$ 2.98B	$ 2.74B	$ 2.65B	$ 2.06B	$ 1.55B
EBITDA	$ ―	$ 3.71B	$ 3.45B	$ 3.27B	$ 2.62B	$ 1.91B

Currency in USD

Shandong Weigao Group Medical Polymer Co Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing